Food/Recall·openFDA/food

Tiffany Food Corp — Class III: Hexing Haw Balls candy; packaged in 200g/0.44 lb./7.05 oz clear plastic bag; Ingredients:

LowPublished Sep 23, 2026· AI-analyzed Sep 29, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

Tiffany Food Corp has initiated a Class III recall for Hexing Haw Balls candy due to the presence of Ponceau 4R, an unapproved dye. The product was manufactured in China and distributed in 200g clear plastic bags.

Who it affects

This recall affects Tiffany Food Corp, food importers, and quality assurance personnel responsible for monitoring additive compliance in imported confectionery products.

Why it matters

A Class III designation indicates that while the product violates FDA regulations regarding unapproved additives, it is unlikely to cause adverse health consequences. However, this enforcement action highlights the ongoing regulatory scrutiny of imported food products containing colorants that are permitted in other jurisdictions (such as China or the EU) but remain unapproved for use in the United States.

Practical takeaway

Quality teams should verify that all imported color additives in finished goods meet US-specific permitted substance lists. Procurement departments should review supplier certificates of analysis for foreign-sourced confectionery products to ensure non-compliant dyes like Ponceau 4R are excluded from formulations.

FDA source material

Class III. Reason: Unapproved dye Ponceau 4R. Product: Hexing Haw Balls candy; packaged in 200g/0.44 lb./7.05 oz clear plastic bag; Ingredients: haw, white sugar, water.; Serving suggestion: ready to eat. Storage: keep in cool and dry place and keep tightly closed in refrigerator after opening.; PRODUCT OF CHINA; UPC 6 920603 810025. Firm: Tiffany Food Corp (Brooklyn NY United States). Status: Ongoing.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.